Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) wane after early infant immunization. METHODS: Children previously immunized in a randomized controlled trial at ages 2, 3, and 4 months with DTPa-IPV-Hib and MenC-CRM197 (MenC-CRM group...
Auteurs principaux: | Khatami, A, Snape, MD, John, T, Westcar, S, Klinger, C, Rollinson, L, Boutriau, D, Mesaros, N, Wysocki, J, Galaj, A, Yu, L, Pollard, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2011
|
Documents similaires
-
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
par: Khatami, A, et autres
Publié: (2012) -
Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
par: Snape, MD, et autres
Publié: (2009) -
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
par: Snape, MD, et autres
Publié: (2006) -
Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
par: Snape, M, et autres
Publié: (2006) -
A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
par: Pace, D, et autres
Publié: (2008)